Menu
Exonate
Exonate develops and licenses Vascular Endothelial Growth Factors (VEGF) control agents that may be used as therapeutics in areas such as pain control, macular degeneration and cancer.
Drug discovery – wet AMD and cancer
School of Medicine
Profile
Exonate’s research in this area has identified therapeutic candidates for wet Age Related Macular Degeneration that can be administered as a simple eye drop, thereby over-coming the unpleasant need for monthly injections in the eye.
Competing injectable anti-VEGFdirected therapy currently constitutes the gold-standard treatment for wet Age Related Macular Degeneration (wAMD) and other neovascular diseases of the eye.
News and press releases
@ExonateUK on Twitter
Exonate are delighted to announce that our COO Dr Loic Lhuillier will be taking part in the Panel Session ’How to negotiate Big Pharma’ 9.30 at BioForward 2021, which provides R&D business leaders with knowledge and skills required to achieve commercial success.
#lifesciences
Exonate are hiring a research scientist in drug discovery on a 4 month position to join exciting projects in RNA splicing therapeutics. Great opportunity for a PhD or equivalent lab experience with molecular biology skills. Apply here https://indeedhi.re/3nVhBMi
As shown in our patient and carer survey, an astonishing 9 out of 10 people had never heard of pulmonary fibrosis before they were diagnosed. With over 30,000 people living with IPF in the UK, more needs to be done 💙💜
#pulmonaryfibrosisawarenessmonth #patientsupport
Today marks the beginning of #NationalEyeHealthWeek and we're delighted to join in with the @CollegeOptomUK #IAmAnOptometrist campaign 👁👏
Throughout the week we'll be posting some expert eye health info to keep you on seeing and feeling your best 💛
Monday marks the start of National Eye Health Week 2021. Join us and help spread the word on eye health using the hashtags #EyeWeek and #VisionMatters. Together we can make a bigger difference and improve the lives of people living across the UK.
About 37 million Americans adults have Chronic Kidney Disease (CKD) & millions more are at an increased risk*. Hear from a panel of scientific experts & entrepreneurs on 9/28 to discuss the latest science that hopes to help overcome CKD challenges https://jji.jnj/ckdtw
Did you know that one of the key contributors to #diabetesdistress could be loss of control or perceived loss of control?
Read more here
https://bit.ly/3vg7i5m
It is #diabetesweek2021. Did you know that there is still stigma and a lack of awareness about #diabetes?
Read more here 👉 https://bit.ly/3vg7i5m
#DiabetesDistress
